Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissueResearch in context
Background: Pancreatic cancer is a heterogenous disease with a poor prognosis. This study aimed to discover and validate prognostic tissue biomarkers in pancreatic cancer using a mass spectrometry (MS) based proteomics approach. Methods: Global protein sequencing of fresh frozen pancreatic cancer an...
Main Authors: | Qimin Zhou, Roland Andersson, Dingyuan Hu, Monika Bauden, Theresa Kristl, Agata Sasor, Krzysztof Pawłowski, Indira Pla, Katarzyna Said Hilmersson, Mengtao Zhou, Fan Lu, György Marko-Varga, Daniel Ansari |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419302427 |
Similar Items
-
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
by: Qimin Zhou, et al.
Published: (2020-02-01) -
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2018-11-01) -
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
by: Monika Bauden, et al.
Published: (2017-12-01) -
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01) -
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
by: Johannes Byrling, et al.
Published: (2020-09-01)